Victor Moyo
Directeur Technique/Scientifique/R&D chez TRAWS PHARMA, INC.
Postes actifs de Victor Moyo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TRAWS PHARMA, INC. | Directeur Technique/Scientifique/R&D | 24/10/2023 | - |
OncoPep, Inc.
 OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Corporate Officer/Principal | 01/05/2022 | - |
Historique de carrière de Victor Moyo
Formation de Victor Moyo
| University of Zimbabwe | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Zimbabwe | 2 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
OncoPep, Inc.
OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Finance |
- Bourse
- Insiders
- Victor Moyo
- Expérience